COVID-19 Testing in the Era of Modern Neurosurgery: Mitigating Risk in Our Vulnerable Patient Populations.
World Neurosurg
; 152: 80-83, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1267966
ABSTRACT
BACKGROUND:
The respiratory illness identified as coronavirus disease 2019 (COVID-19) has resulted in a pandemic illness that has changed the face of healthcare. As the COVID-19 pandemic continues, patients have continued to require neurosurgical interventions, and the endoscopic endonasal approach for surgery has continued to be a mainstay treatment of pituitary tumors and anterior skull base lesions.METHODS:
We sought to highlight the current lack of recommendations regarding testing protocols for neurosurgical patients.RESULTS:
We implemented a novel testing protocol for our patient populations at increased risk and have proposed a model that can be used at other institutions to mitigate the risk of complications associated with some forms of COVID-19 testing.CONCLUSION:
Patients with anterior skull base defects may be at risk with current COVID-19 testing protocols, and may benefit from alternative specimen collection strategies.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Neurosurgical Procedures
/
COVID-19 Testing
/
SARS-CoV-2
/
COVID-19
Type of study:
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
World Neurosurg
Journal subject:
Neurosurgery
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS